Study Description: To determine which venous access device - subcutaneously tunnelled central catheters (Hickman type device), peripherally inserted central catheters (PICC) or implantable chest wall ports (Port), offers the best outcome from safety, clinical effectiveness and cost effectiveness perspectives.
Study Design: A randomised controlled trial incorporating pre and post trial qualitative research
Trial Status: Open
Chief Investigator: Professor Jon Moss
Sponsor: NHS Greater Glasgow and Clyde
Date Opened: 08 November 2013
Planned Closure Date: 30 November 2017
Target Recruitment: 1400
Open to New Sites: Yes
Contact Details: Clinical Trial Unit (CTU), Glasgow
Eileen Soulis/Susan Dillon
Click here to download the Initiation Slides
Click here to download the Protocol
For advice on reporting any unexpected events for the device to the MHRA please contact:
The Pharmacovigilance Team email: [email protected] or
Telephone: 0141 211 0352/0203/3567/3968 or 0141 232 2068
Version of NCI Common Terminology Criteria for Adverse Events (CTCAE) being used for the study: 4.2
Click here to download the CTCAE
